Literature DB >> 23043906

Thrombin promotes the expression of thrombospondin-1 and -2 in a rat model of intracerebral hemorrhage.

A-Li Yang1, Hua-Jun Zhou, Yuan Lin, Jie-Kun Luo, Han-Jin Cui, Tao Tang, Qi-Dong Yang.   

Abstract

Spontaneous intracerebral hemorrhage (ICH) is one of the most severe types of stroke. Thrombin has been reported to participate in brain repair following ICH and play an important role in angiogenesis. Our previous studies have shown that ICH induces angiogenesis in damaged rat brain, accompanied by upregulation of expression of thrombospondin (TSP)-1 and TSP-2. The aim of the present study was to investigate whether the expression of TSP-1 and TSP-2 was regulated by thrombin in rat brain following ICH. A rat model of ICH was induced by injection of autologous blood into the right globus pallidus (GP). Hirudin, a thrombin specific inhibitor, or thrombin was injected into the GP. Immunohistochemistry, quantitative real-time reverse-transcription polymerase chain reaction (RT-PCR) and western blot assays were applied. Results showed that ICH induced an increase in the expression of TSP-1 mRNA and TSP-2 mRNA after ICH, whereas hirudin significantly inhibited the expression of TSPs mRNA after ICH (P<0.05). In contrast, sole thrombin treatment in normal rats induced strong expression of TSP-1 or TSP-2 in the blood vessels around the damaged brain region when compared with those without thrombin treatment. Western blot analysis data confirmed that the protein levels of TSPs were significantly increased when compared with those in the sham control group (P<0.01). These findings support that thrombin positively regulates the expression of TSP-1 and TSP-2 after ICH, which may be involved in modulating angiogenesis in injured brains following ICH.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043906     DOI: 10.1016/j.jns.2012.09.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Thrombospondin-4 Promotes Neuronal Differentiation of NG2 Cells via the ERK/MAPK Pathway.

Authors:  Hai Jie Yang; Shuang Ping Ma; Fei Ju; Ya Ping Zhang; Zhi Chao Li; Bin Bin Zhang; Jun Jiang Lian; Lei Wang; Bin Feng Cheng; Mian Wang; Zhi Wei Feng
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

2.  Plasminogen deficiency causes reduced angiogenesis and behavioral recovery after stroke in mice.

Authors:  Jinghuan Fang; Michael Chopp; Hongqi Xin; Li Zhang; Fengjie Wang; William Golembieski; Zheng Gang Zhang; Li He; Zhongwu Liu
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-14       Impact factor: 6.200

3.  Early Tranexamic Acid Administration After Traumatic Brain Injury Is Associated With Reduced Syndecan-1 and Angiopoietin-2 in Patients With Traumatic Intracranial Hemorrhage.

Authors:  Taylor N Anderson; Holly E Hinson; Elizabeth N Dewey; Elizabeth A Rick; Martin A Schreiber; Susan E Rowell
Journal:  J Head Trauma Rehabil       Date:  2020 Sep/Oct       Impact factor: 3.117

4.  Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner.

Authors:  Svetlana F Khaiboullina; Sergey P Morzunov; Stephen C St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

5.  Effect of ephrin-B2 on the expressions of angiopoietin-1 and -2 after focal cerebral ischemia/reperfusion.

Authors:  Hui Xiao; Qing Huang; Jia-Qi Wang; Qing-Qing Deng; Wen-Ping Gu
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

6.  Natural Hirudin Increases Rat Flap Viability by Anti-Inflammation via PARs/p38/NF-κB Pathway.

Authors:  Liu Peng; Xinyuan Pan; Guoqian Yin
Journal:  Biomed Res Int       Date:  2015-12-07       Impact factor: 3.411

Review 7.  The Roles of Thrombospondins in Hemorrhagic Stroke.

Authors:  Xuan Wu; Xu Luo; Qiquan Zhu; Jie Zhang; Yun Liu; Hansheng Luo; Yuan Cheng; Zongyi Xie
Journal:  Biomed Res Int       Date:  2017-10-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.